Bridging the Gap, Accelerating the Path to Cure with Strategic Funding Solutions

Sabine Hutchison talks to the inspiring investor Stephanie Oestreich.In the first episode of season 2, host Sabine Hutchison, Seuss+ CEO and Co-Founder, is joined by the inspiring Stephanie Oestreich, whose work at the Myeloma Investment Fund (MIF) involves applying financial investment, scientific knowledge and valuable connections to reach a cure for every single Myeloma patient.At MIF, Stephanie uses the investment and drug development knowledge and skills she has gained in several leadership roles in biotech and big pharma.In this engaging conversation, Sabine talks to Stephanie about the challenges involved in running a specialty fund, and what she looks for in potential investments. Stephanie shares that MIF’s North Star is finding a cure for patients, and why it’s valuable for investors to visit clinical trial sites to see their work in action. Stephanie Oestreich – BioStephanie Oestreich is Managing Director of the Myeloma Investment Fund (MIF). She serves on the boards of the German American Business Council in Boston and the Harvard Kennedy School’s Women’s Network and is the chair of the McCloy Alumni Association.She is also on the faculty of MIT, a member of the Launchpad Venture Group, an advisor at grIP Venture Studio, to Biognosys (a Bruker company), Invitris, CART company CelineTx and to the drug development and investment company OrangeGrove Bio, Additionally she works on the W20 Entrepreneurship task force, the official engagement group of the G20.Stephanie has held several leadership roles in biotech, including Chief Business Officer at Galecto, Vice President at cell therapy company Mnemo Therapeutics, Venture Partner at RA Capital and Executive Vice President at Evotec, where she built its North American investment arm and started an incubator with Samsara BioCapital. She has worked as International Business Leader at F. Roche Hoffmann-La Roche Ltd., and for Novartis in Business Development and in Commercial.Stephanie conducted the research for her Ph.D. in biochemistry in the lab of a Nobel Prize winner at Harvard Medical School and obtained an MPA from the Harvard Kennedy School.She is also a semi-professional violinist, performing with Philharmonic orchestras in Carnegie Hall and other international venues and conducting workshops with live orchestras, demonstrating the similarities between teams and leadership in music and management.Join the discussion and listen to the full episode here.

There are no comments yet.

Please log in to write the first comment.